A Study to Understand the Utility of the Force Feedback Instruments in Robotic Procedures Using da Vinci 5 Robot
A Prospective, Post-Market Study to Evaluate the Clinical Utility of the Force Feedback Instruments in RAS Procedures Using the da Vinci 5 Surgical System
Study Overview
Status
Status
Conditions
Conditions
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Smruthi Srinivasa Murthy
- Phone Number: 682-552-6131
- Email: smruthi.srinivasamurthy@intusurg.com
Study Contact Backup
- Name: Manish Bharara
- Email: manish.bharara@intusurg.com
Study Locations
-
-
California
-
San Diego, California, United States, 92123
- Sharp Memorial Hospital
-
-
Florida
-
Miami, Florida, United States, 33136
- University of Miami
-
-
Georgia
-
Gainesville, Georgia, United States, 30501
- Northeast Georgia Medical Center, Inc
-
-
Illinois
-
Chicago, Illinois, United States, 60611
- Northwestern Memorial Healthcare
-
-
Ohio
-
Columbus, Ohio, United States, 43210
- Ohio State University
-
-
Texas
-
Austin, Texas, United States, 78758
- St. David's Healthcare
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Pre-Operative Inclusion Criteria:
- Age 22 years or older
- ASA ≤ 3
- The clinical decision has been made to perform multi-port robotic assisted surgery with da Vinci 5 with Force Feedback instruments for the study specified procedure as primary procedure prior to enrollment in the study
- Subject or a legally authorized representative is able to provide written informed consent using the study informed consent form prior to the study
- Subject is willing and able to comply with the study protocol requirements including follow up schedule
Pre-operative Exclusion Criteria:
- Subject receiving an emergent procedure
- Subject planned to undergo major concomitant surgery for the treatment of a different medical condition than was originally planned
- Subject with previous ipsilateral surgery (open, endoscopic or robotic) with the same surgical indication
- Subject with past or ongoing medical conditions (for example: inflammatory bowel disease) which, in the judgment of the Investigator, puts them at high risk for surgery and not appropriate for the study
- Subject is pregnant or suspected to be pregnant or breastfeeding
- Subject has any other condition or personal circumstance that, in the judgment of the Investigator, might interfere with the collection of complete quality data
- Subject is currently participating in or has participated in a study of an investigational agent or a significant risk investigational device study within the past 6 months
- Subject belongs to a vulnerable population.
- Subject is contraindicated for anesthesia or surgery.
Intra-operative Exclusion Criteria
- Subject with hemodynamic or respiratory instability, which precludes the Investigator from performing the RAS.
- Subject in whom inadequate visualization makes a minimally invasive approach not feasible, as determined from the investigator assessment prior to docking the robot.
- Subject with adhesions, scarring and disease status in the body which in the opinion of the investigator limits the ability to perform the minimally invasive procedure.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
To assess the force imparted on the tissue by force feedback instruments.
Time Frame: Intra-operative
|
Intra-operative
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
To evaluate the utility of force feedback instruments during specific procedural steps or tasks.
Time Frame: Post-operative prior to discharge
|
Post-operative prior to discharge
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- ISI-dV5-MP-01
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.